The design and implementation of the immune epitope database and analysis resource

被引:83
作者
Peters, B
Sidney, J
Bourne, P
Bui, HH
Buus, S
Doh, G
Fleri, W
Kronenberg, M
Kubo, R
Lund, O
Nemazee, D
Ponomarenko, JV
Sathiamurthy, M
Schoenberger, SP
Stewart, S
Surko, P
Way, S
Wilson, S
Sette, A
机构
[1] La Jolla Inst Allergy & Immunol, San Diego, CA 92109 USA
[2] San Diego Supercomp Ctr, San Diego, CA 92186 USA
[3] Univ Copenhagen, DK-220 Copenhagen, Denmark
[4] SH Grace Consulting, Seoul 140210, South Korea
[5] Tech Univ Denmark, Bioctr DTU, DK-2800 Lyngby, Denmark
[6] Scripps Res Inst, Dept Immunol, La Jolla, CA 92037 USA
[7] Sci Applicat Int Corp, San Diego, CA 92121 USA
关键词
epitope; antibody; MHC; database;
D O I
10.1007/s00251-005-0803-5
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Epitopes are defined as parts of antigens interacting with receptors of the immune system. Knowledge about their intrinsic structure and how they affect the immune response is required to continue development of techniques that detect, monitor, and fight diseases. Their scientific importance is reflected in the vast amount of epitope-related information gathered, ranging from interactions between epitopes and major histocompatibility complex molecules determined by X-ray crystallography to clinical studies analyzing correlates of protection for epitope based vaccines. Our goal is to provide a central resource capable of capturing this information, allowing users to access and connect realms of knowledge that are currently separated and difficult to access. Here, we portray a new initiative, "The Immune Epitope Database and Analysis Resource." We describe how we plan to capture, structure, and store this information, what query interfaces we will make available to the public, and what additional predictive and analytical tools we will provide.
引用
收藏
页码:326 / 336
页数:11
相关论文
共 103 条
[31]   Ontology for immunogenetics: the IMGT-ONTOLOGY [J].
Giudicelli, V ;
Lefranc, MP .
BIOINFORMATICS, 1999, 15 (12) :1047-1054
[32]   Antigen degradation or presentation by MHC class I molecules via classical and non-classical pathways [J].
Grommé, M ;
Neefjes, J .
MOLECULAR IMMUNOLOGY, 2002, 39 (3-4) :181-202
[33]  
Grufman P, 1999, EUR J IMMUNOL, V29, P2197, DOI 10.1002/(SICI)1521-4141(199907)29:07<2197::AID-IMMU2197>3.0.CO
[34]  
2-B
[35]   PROMISCUOUS AND ALLELE-SPECIFIC ANCHORS IN HLA-DR-BINDING PEPTIDES [J].
HAMMER, J ;
VALSASNINI, P ;
TOLBA, K ;
BOLIN, D ;
HIGELIN, J ;
TAKACS, B ;
SINIGAGLIA, F .
CELL, 1993, 74 (01) :197-203
[36]   Structure of a covalently stabilized complex of a human αβ T-cell receptor, influenza HA peptide and MHC class II molecule, HLA-DR1 [J].
Hennecke, J ;
Carfi, A ;
Wiley, DC .
EMBO JOURNAL, 2000, 19 (21) :5611-5624
[37]   Fine specificity of autoantibodies to soluble liver antigen and liver/pancreas [J].
Herkel, J ;
Heidrich, B ;
Nieraad, N ;
Wies, I ;
Rother, M ;
Lohse, AW .
HEPATOLOGY, 2002, 35 (02) :403-408
[38]   Toward a definition of self: Proteomic evaluation of the class I peptide repertoire [J].
Hickman, HD ;
Luis, AD ;
Buchli, R ;
Few, SR ;
Sathiamurthy, M ;
VanGundy, RS ;
Giberson, CF ;
Hildebrand, WH .
JOURNAL OF IMMUNOLOGY, 2004, 172 (05) :2944-2952
[39]  
Horwood F, 2002, THORAX, V57, P24
[40]  
Imami Nesrina, 2003, J HIV Ther, V8, P15